Dianthus Therapeutics, INC. /De/ (DNTH) — SC 13G Filings

All SC 13G filings from Dianthus Therapeutics, INC. /De/. Browse 6 Passive Stake Filing reports with AI-powered summaries and risk analysis.

SC 13G Filings (6)

SC 13G Filing — Nov 22, 2024
SC 13G Filing — Nov 8, 2024
SC 13G Filing — Oct 24, 2024
SC 13G Filing — Oct 11, 2024
BCLS Fund III Investments Takes 5.0% Stake in Dianthus Therapeutics — Feb 2, 2024
BCLS Fund III Investments, LP, a Boston-based investment fund, has reported a significant stake in Dianthus Therapeutics, Inc. /DE/, a pharmaceutical company. A
RA Capital Discloses Significant Stake in Dianthus Therapeutics — Feb 2, 2024
RA Capital Management, L.P., a Boston-based investment firm, filed an SC 13G on February 2, 2024, disclosing its ownership in Dianthus Therapeutics, Inc. /DE/.

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX